The FTC is preparing a lawsuit against the three largest PBMs—OptumRx, Express Scripts, and CVS Caremark—over allegations that they steered patients to more expensive drugs in exchange for manufacturer rebates.
The news follows the release of an interim report by the agency criticizing business practices, consolidation, and vertical integration by PBMs.
Strategist | strategy-catalyst
FTC to sue major PBMs over drug rebate tactics
Relevant Roles:
Chief Strategy Officers